| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JQ-1 | GDSC1000 | pan-cancer | AAC | -0.037 | 0.2 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | VX-680 | GDSC1000 | pan-cancer | AAC | 0.058 | 0.3 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | Axitinib | FIMM | pan-cancer | AAC | 0.18 | 0.3 |
| mRNA | MG-132 | GDSC1000 | pan-cancer | AAC | -0.053 | 0.3 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.3 |